340B Delayed Regulations on Transparency and CMPs
Defendants moved for a stay of this case pending the resolution of a planned rulemaking in which the Department of Health and Human Services would propose that the 340B Drug Pricing Rule take effect on January 1, 2019.
Download the full notice below.
AHA v. The Department of Health and Human Services Reply in Support of Defendants' Motion for a Stay
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA
THE AMERICAN HOSPITAL ASSOCIATION, et al., Plaintiffs,
v.
THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, et al., Defendants.
No. 1:18-cv-02112-JDB
REPLY IN SUPPORT OF DEFENDANTS’ MOTION FOR A STAY
Plaintiffs' Memorandum in Opposition to Defendants' Motion to Stay
This action challenges Defendants' protracted delays in implementing 2010 amendments to 42 USC 256b, which governs the program by which hospitals, community health centers, and other federally funded clinics that disproportionately…
Defendants hereby request that the Court (1) stay this case pending the outcome of the U.S. Department of Health and Human Services' planned rulemaking that may moot the case or limit the issues to be decided by the Court, or in the alternative, (2) stay briefing of plaintiffs' early summary…
The AHA, Association of American Medical Colleges, America’s Essential Hospitals, 340B Health and three hospital systems today asked a federal court to order the Department of Health and Human Services to make effective within 30 days a final rule requiring drug companies to disclose the ceiling…
September 11, 2018: The AHA, Association of American Medical Colleges, America’s Essential Hospitals, 340B Health and three hospital systems today asked a federal court to order the Department of Health and Human Services to make effective within 30 days a final rule requiring drug companies to…